The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc.

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Topline results from a second phase 3 trial of AD109-an investigational oral therapy combining aroxybutynin and ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?

Sleep apnea is a condition where breathing repeatedly stops or reduces during sleep, often due to airway obstruction. It ...

The sleep apnea detection feature that Apple's most recent Apple Watch models offer has expanded to several more countries in ...

Sleep apnea is a sleep disorder that causes a disruption in your breathing. Here's what to know about symptoms and treatment for sleep apnea.

Sleep apnea is a common and serious sleep disorder that causes your breathing to become shallow or stop completely during sleep. In some cases, this pause in breathing (called apnea) can last 10 ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

Sleep apnea may result in poor sleep and lead to daytime sleepiness. It is often associated with snoring too. Between 12 and 18 million U.S. adults have sleep apnea. Sleep apnea: Causes.